Therapy News and Research

RSS

Bayer enrolls patients for Phase III trial of Stivarga (regorafenib) tablets in colorectal cancer

Bayer HealthCare today announced that the company has begun to enroll patients in the COAST trial studying Stivarga® (regorafenib) tablets in colorectal cancer (CRC) patients with resected liver metastases.

20 Feb 2014

Researchers develop screening assay that quickly assesses nearly 1,500 compounds' effect on estrogen

A team of researchers at City of Hope has developed a screening assay that can quickly assess up to 1,536 compounds' effect on estrogen activity in the body. The test can also evaluate whether chemicals act as inhibitors of aromatase, an enzyme linked to breast cancer that converts androgen to estrogen.

20 Feb 2014

Purdue’s new innovation improves drug therapies by making real-time decisions about treatment options

Oncologists and cancer patients could improve the results of drug therapies by making real-time decisions about treatment options using an innovation developed in Purdue University's College of Pharmacy.

20 Feb 2014

Vaccine-based clinical trial to improve survival outcomes of kidney cancer patients

The Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute has opened a novel Phase III, vaccine-based clinical trial aimed at providing kidney cancer patients long-term control of their disease.

20 Feb 2014

Premature babies who receive interventional therapy plus mother's voice learn to eat efficiently

Premature babies who receive an interventional therapy combining their mother's voice and a pacifier-activated music player learn to eat more efficiently and have their feeding tubes removed sooner than other preemies, according to a Monroe Carell Jr. Children's Hospital at Vanderbilt study published today in Pediatrics.

20 Feb 2014

Breast cancer patients receiving radiotherapy show decreased fatigue as result of CBTH

Breast cancer patients receiving radiotherapy showed decreased fatigue as a result of cognitive behavioral therapy plus hypnosis (CBTH), according to a study recently published in the Journal of Clinical Oncology.

20 Feb 2014

NIH-funded session in Bethesda to heighten awareness of underactive bladder

Underactive bladder, estimated to affect more than 20 percent of the elderly population, is an unrecognized disease that has a major influence on the health and independence of seniors.

20 Feb 2014

Addition of confocal laser endomicroscopy to HDWLE improves diagnosis of Barrett's esophagus

New research shows that the addition of confocal laser endomicroscopy to high-definition white-light endoscopy enables improved real-time endoscopic diagnosis of Barrett's esophagus dysplasia (neoplastic tissue) by using targeted biopsies of abnormal mucosa to reduce unnecessary mucosal biopsies and potentially reduce costs.

20 Feb 2014

Genetic profiles obtained from nasal passages guide individualized therapy, research

It has become increasingly clear in recent years that asthma comes in several variations, with different causes, different pathologies and different responses to therapy.

20 Feb 2014

BONESUPPORT launches new registry to collect data of CERAMENT™|G to protect bone infections

BONESUPPORT, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic surgery, announced today the launch of a new registry to collect long term data of CERAMENT™|G, the first injectable antibiotic eluting, osteoconductive, ceramic bone substitute indicated to promote and protect bone healing being jeopardized by infection.

20 Feb 2014

CardioCell announces new clinical trials using allogeneic stem-cell therapy to treat subjects with AMI

CardioCell LLC announces two new clinical trials using its allogeneic stem-cell therapy to treat subjects with acute myocardial infarction (AMI), a problem facing more than 1.26 million Americans annually.

20 Feb 2014

NYU Langone and SonaCare Medical join forces to advance therapeutic ultrasound technology

NYU Langone Medical Center and SonaCare Medical, LLC (SonaCare Medical), a global leader in minimally invasive focused therapeutic ultrasound technologies, announced a collaboration to develop tools and clinical procedures based on the use of advanced focused therapeutic ultrasound technology.

20 Feb 2014

Deficiency in SNX27 explains learning impairment in Down's syndrome

Scientists at A*STAR's Institute of Molecular and Cell Biology (IMCB) have identified the precise role of the protein, SNX27, in the pathway leading to memory and learning impairment.

20 Feb 2014

Antidepressant medication shows potential in treating symptoms of agitation that occur with AD

An antidepressant medication has shown potential in treating symptoms of agitation that occur with Alzheimer's disease and in alleviating caregivers' stress, according to a multi-site U.S.- Canada study.

20 Feb 2014

DHS expands business and product offerings with the acquisition of Reliable Home Medical Equipment

Dynamic Healthcare Services, Inc., a portfolio company of GMH Ventures LLC and Lakewood Capital, LLC, announced today that it acquired Reliable Home Medical Equipment, Inc. of Hackensack, NJ on February 10th, 2014. The terms of the acquisition were not disclosed.

20 Feb 2014

Researcher receives Pioneer Award for engineering herpes simplex virus gene delivery systems

Joseph C. Glorioso, III, PhD (University of Pittsburgh School of Medicine, PA) devoted much of his research career to developing herpes viruses as efficient vectors for delivering therapeutic genes into cells.

20 Feb 2014

Cystinosis Research Foundation granted $2.15M in 2013 to researchers investigating cure for cystinosis

The Cystinosis Research Foundation awarded $2,153,048 in 2013 to researchers investigating better treatments and a cure for cystinosis, a rare metabolic and genetic disease that afflicts about 500 children and young adults in the United States and 2,000 worldwide.

19 Feb 2014

Indacaterol/glycopyrronium drug combination offers added benefit for adults with COPD

The drug combination indacaterol/glycopyrronium (trade name: Ultibro Breezhaler, Xoterna Breezhaler) has been approved since September 2013 for adults with chronic obstructive pulmonary disease (COPD).

19 Feb 2014

iCAD total revenue for Q4 2013 increases 16.8% to $9.1 million

iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today reported financial results for the three and twelve months ended December 31, 2013.

19 Feb 2014

Nintedanib plus docetaxel shows second-line efficacy in recurrent NSCLC

Nintedanib plus docetaxel offers significant efficacy in patients with non-small-cell lung cancer who experience disease progression after first-line chemotherapy, phase III study results show.

19 Feb 2014

Therapy News and Research

Bayer enrolls patients for Phase III trial of Stivarga (regorafenib) tablets in colorectal cancer

Researchers develop screening assay that quickly assesses nearly 1,500 compounds' effect on estrogen

Purdue’s new innovation improves drug therapies by making real-time decisions about treatment options

Vaccine-based clinical trial to improve survival outcomes of kidney cancer patients

Premature babies who receive interventional therapy plus mother's voice learn to eat efficiently

Breast cancer patients receiving radiotherapy show decreased fatigue as result of CBTH

NIH-funded session in Bethesda to heighten awareness of underactive bladder

Addition of confocal laser endomicroscopy to HDWLE improves diagnosis of Barrett's esophagus

Genetic profiles obtained from nasal passages guide individualized therapy, research

BONESUPPORT launches new registry to collect data of CERAMENT™|G to protect bone infections

CardioCell announces new clinical trials using allogeneic stem-cell therapy to treat subjects with AMI

NYU Langone and SonaCare Medical join forces to advance therapeutic ultrasound technology

Deficiency in SNX27 explains learning impairment in Down's syndrome

Antidepressant medication shows potential in treating symptoms of agitation that occur with AD

DHS expands business and product offerings with the acquisition of Reliable Home Medical Equipment

Researcher receives Pioneer Award for engineering herpes simplex virus gene delivery systems

Cystinosis Research Foundation granted $2.15M in 2013 to researchers investigating cure for cystinosis

Indacaterol/glycopyrronium drug combination offers added benefit for adults with COPD

iCAD total revenue for Q4 2013 increases 16.8% to $9.1 million

Nintedanib plus docetaxel shows second-line efficacy in recurrent NSCLC

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News